| human | Q5 |
| P227 | GND ID | 1252594828 |
| P269 | IdRef ID | 077050703 |
| P213 | ISNI | 0000000041028932 |
| P2798 | Loop ID | 314121 |
| 351276 | ||
| P496 | ORCID iD | 0000-0002-0685-0765 |
| 0000-0003-4245-2227 | ||
| P1053 | ResearcherID | F-6348-2013 |
| P1153 | Scopus author ID | 7005145349 |
| P214 | VIAF ID | 41239974 |
| P69 | educated at | Harvard Medical School | Q49121 |
| Boston University School of Medicine | Q4119659 | ||
| Aristotle University of Thessaloniki | Q667568 | ||
| P108 | employer | National and Kapodistrian University of Athens | Q547867 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q33693227 | "Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD. |
| Q44790534 | 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. |
| Q31070032 | A 10-year aerobiological study (1994-2003) in the Mediterranean island of Crete, Greece: trees, aerobiologic data, and botanical and clinical correlations. |
| Q92505560 | A 63-Year-Old Woman With Pulmonary Micronodules and Chronic Cough |
| Q49959043 | A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass |
| Q48181607 | A fatty meal aggravates apnea and increases sleep in patients with obstructive sleep apnea |
| Q37437467 | Acute fibrinous and organising pneumonia: a case report and review of the literature. |
| Q37885000 | Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult. |
| Q28298430 | An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias |
| Q34882979 | Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? |
| Q45190301 | Anti-acid treatment for idiopathic pulmonary fibrosis. |
| Q37337820 | Apoptosis in lung injury and fibrosis. |
| Q24799102 | Application of microarray technology in pulmonary diseases |
| Q51698033 | Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. |
| Q53321598 | Biomarkers in Idiopathic Pulmonary Fibrosis: A RAGE-ing Bull in the Arena. |
| Q38111794 | Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification. |
| Q43737696 | Bronchoalveolar lavage fluid cellular profile in workers exposed to chrysotile asbestos. |
| Q83398238 | Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias |
| Q47983947 | Bronchoscopic lung volume reduction: a window for the future? |
| Q48133009 | COPD and IPF: it's all about regulation and balance. |
| Q21257182 | COPD exacerbation: lost in translation |
| Q51549774 | Cardiopulmonary Exercise Testing in Systemic Sclerosis: 'Ars longa, vita brevis'. |
| Q39901097 | Changes in tuberculin sensitivity among first-grade students of elementary schools in Evros, Greece due to immigration. |
| Q103826929 | Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study |
| Q80452478 | Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study |
| Q77700549 | Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer |
| Q64079377 | Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort |
| Q38919001 | Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract. |
| Q22241379 | Community acquired bacterial pneumonia |
| Q35206336 | Comparative analysis of induced sputum and bronchoalveolar lavage fluid (BALF) profile in asbestos exposed workers |
| Q80969911 | Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis |
| Q90818203 | Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: A case report |
| Q33990489 | Current and future therapeutic approaches in idiopathic pulmonary fibrosis. |
| Q38002550 | Current evidence for the management of paediatric parapneumonic effusions. |
| Q37239197 | Current pharmacological treatment of pulmonary arterial hypertension. |
| Q48387155 | Determinants of continuous positive airway pressure compliance in a group of Greek patients with obstructive sleep apnea. |
| Q42101627 | Diagnosis of Idiopathic Pulmonary Fibrosis "Pragmatic Challenges in Clinical Practice" |
| Q91247291 | Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline |
| Q39039977 | Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient's "Q and A" approach |
| Q93362188 | Diagnostic guidelines for IPF: when art meets science |
| Q92001004 | Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern |
| Q58239697 | Diagnostic value of ferritin, haptoglobin, α1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation |
| Q77753846 | Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions |
| Q79225746 | Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis |
| Q70896606 | Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis |
| Q47829582 | Dissecting Survival Pathways in Lung Cancer, Fibrosis and Emphysema: "The Four Horses of the Apocalypse". |
| Q43153864 | Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis. |
| Q104494962 | Early COVID-19 Lockdown in Greece and IPF: A beneficial "impact" beyond any expectation |
| Q95365440 | Editorial |
| Q81415816 | Effect of passive smoking on lung function and respiratory infection |
| Q73861057 | Effectiveness of Tc-99m sestamibi compared to Ga-67 in patients with pulmonary sarcoidosis |
| Q80056813 | Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis |
| Q89497773 | Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study |
| Q44498731 | Endoluminal metastases of the tracheobronchial tree : is there any way out? |
| Q73542380 | Eosinophilic pleural effusion due to gliclazide |
| Q47813599 | Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests |
| Q43857924 | Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. |
| Q83193284 | Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis |
| Q90995775 | Existing and emerging treatments for idiopathic pulmonary fibrosis |
| Q81281274 | Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis |
| Q46814088 | Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. |
| Q73234765 | Fat embolism syndrome: clinical examination is still the preferable diagnostic method |
| Q64048422 | Fine-needle aspiration cytology of a para-aortical solitary plasma-cell tumor |
| Q73136764 | Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma |
| Q77929404 | Gastroesophageal reflux presented with haemoptysis and carinal erythematous lesion resembling in situ carcinoma |
| Q38155902 | H2AX a promising biomarker for lung cancer: a review |
| Q85662325 | H2AX and lung cancer: is it the Ariadne's thread? |
| Q48478998 | Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome). |
| Q51713531 | Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. |
| Q92253099 | Human pentraxin 2 protein treatment for IPF |
| Q36818173 | Hypoglycaemia due to interaction of glimepiride with isoniazid in a patient with type 2 diabetes mellitus. |
| Q47836551 | IL-18: a role in nonspecific interstitial pneumonitis pathogenesis and discrimination? |
| Q51459247 | Idiopathic Pulmonary Fibrosis and Emphysema: Between Scylla and Charybdis. |
| Q91594663 | Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name? |
| Q45078315 | Idiopathic pulmonary fibrosis acute exacerbations: where are we now? |
| Q48129735 | Idiopathic pulmonary fibrosis: on the move. |
| Q71836598 | Idiopathic pulmonary haemosiderosis and autoimmune hypothyroidism: bronchoalveolar lavage findings after cimetidine treatment |
| Q21296681 | Idiopathic pulmonary hemosiderosis in adults: a case report and review of the literature |
| Q34734509 | Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. |
| Q84843184 | Increased long-term mortality in healthcare-acquired pneumonia: another short-term lease on life? |
| Q37999465 | Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease. |
| Q33984737 | Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? |
| Q79349589 | Infliximab-induced non-specific interstitial pneumonia and lupus-like eruption |
| Q53017986 | Inherent weaknesses of the current ICD coding system regarding idiopathic pulmonary fibrosis. |
| Q24599153 | Inhibition and role of let-7d in idiopathic pulmonary fibrosis |
| Q84153649 | Interferon gamma for idiopathic pulmonary fibrosis |
| Q92763554 | Interstitial lung abnormalities: ignotum per ignotius |
| Q36627482 | Intrapleural fibrinolytic therapy for pleural infection. |
| Q82382971 | Intrapleural r-tPA in association with low-molecular heparin may cause massive hemothorax resulting in hypovolemia |
| Q38542162 | Investigation of Lung Involvement in Connective Tissue Disorders. |
| Q79926289 | Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location |
| Q80141248 | Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic [corrected] study |
| Q82837517 | Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas |
| Q83149794 | Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis |
| Q44422793 | Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients |
| Q51618038 | Lung Involvement in Rheumatic Disease: Introduction. |
| Q38854869 | Lung cancer in patients with idiopathic pulmonary fibrosis. |
| Q58770940 | Lung function changes after chemoradiation therapy in patients with lung cancer treated by three usual platinum combinations |
| Q74841433 | Lung function in patients with inflammatory bowel disease |
| Q45790810 | Management of pleural empyema: don't miss the point! |
| Q51565969 | Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis. |
| Q87423124 | Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities |
| Q37976241 | Mechanisms of pleural involvement in orphan diseases. |
| Q55379594 | Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis. |
| Q49795481 | Metabolic Disorders in Chronic Lung Diseases |
| Q90214693 | Metformin in Idiopathic Pulmonary Fibrosis "Seeking the Holy-Grail through Drug-Repositioning" |
| Q47746344 | Metsovo Lung: A Story of Episteme, Techne, and Phronesis |
| Q78053936 | Microsatellite DNA instability in COPD |
| Q46220813 | Multinodular pulmonary amyloidosis in primary Sjögren's syndrome. |
| Q92599322 | Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
| Q71232770 | Natural history of patients with pulmonary metastases from uterine cancer |
| Q37390883 | New developments in the management of COPD: clinical utility of indacaterol 75 μg. |
| Q88473311 | Nintedanib in Severe Idiopathic Pulmonary Fibrosis: Effectiveness through Compassion |
| Q82892669 | Noninvasive ventilation in acute pancreatitis respiratory failure: deus ex machina? |
| Q48338987 | Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep |
| Q40379874 | Orthodeoxia and platypnoea after acute organophosphorus poisoning reversed by CPAP: a newly described cause and review of the literature. |
| Q36413496 | Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. |
| Q47680431 | Patients with IPF and lung cancer: diagnosis and management. |
| Q43255615 | Penetration of azithromycin in experimental pleural empyema fluid |
| Q46533728 | Penetration of clarithromycin in experimental pleural empyema model fluid. |
| Q51799765 | Perforin down-regulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and BAL study. |
| Q33381328 | Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma |
| Q84100539 | Pirfenidone for idiopathic pulmonary fibrosis |
| Q46054334 | Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome. |
| Q37282194 | Pleural effusions in critically ill patients. |
| Q51639674 | Pleural fluid polymorphonuclear elastase: cui bono? |
| Q44050128 | Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters. |
| Q74316743 | Pleurodesis: everything flows |
| Q87961880 | Pleuroscopy in 'Idiopathic' eosinophilic pleural effusions |
| Q78168334 | Pneumoconiosis among Cretan dental technicians |
| Q74079246 | Pneumonology or pneumology?: An etymologic approach |
| Q77867345 | Pneumothorax complicating fatal bronchiolitis obliterans organizing pneumonia |
| Q37200021 | Post-intubation pulmonary embolism and tracheal stenosis: a case report and review of the literature. |
| Q44949087 | Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. |
| Q84326037 | Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters |
| Q45035757 | Prevention of nosocomial maxillary sinusitis in the ICU: the effects of topically applied alpha-adrenergic agonists and corticosteroids. |
| Q84491648 | Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis |
| Q83069668 | Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification |
| Q52616187 | Pulmonary hypertension in patients with interstitial lung disease. |
| Q35685902 | Pulmonary lymphangioleiomyomatosis associated with retroperitoneal lymphangioleiomyomas |
| Q40289811 | Quality of life in patients with active sarcoidosis in Greece. |
| Q47321710 | Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. |
| Q43564427 | Reduction in cotton dust concentration does not totally eliminate respiratory health hazards: the Greek study. |
| Q43132590 | Reduction of serum retinol-binding protein-4 levels in nondiabetic obstructive sleep apnea patients under continuous positive airway pressure treatment. |
| Q80784468 | References to tuberculosis in Greek popular music (Rebetico) |
| Q38064670 | Regenerative medicine and stem cells: prometheus revisited. |
| Q44498454 | Respiratory muscle strength and lung function in patients undergoing medical thoracoscopy. |
| Q72221690 | Respiratory muscle strength during continuous ambulatory peritoneal dialysis (CAPD) |
| Q36574815 | Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. |
| Q38215158 | S100A2 protein and non-small cell lung cancer. The dual role concept. |
| Q92851876 | Safety and Efficacy of Early and Long-Term Use of Pirfenidone in Idiopathic Pulmonary Fibrosis |
| Q24815239 | Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator |
| Q44114292 | Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. |
| Q73735774 | Short-term effects of wood smoke exposure on the respiratory system among charcoal production workers |
| Q47916492 | Sleep apnea syndrome and diastolic blood pressure elevation during exercise. |
| Q45281655 | Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. |
| Q48323400 | Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. |
| Q83092246 | Smoking acutely increases plasma ghrelin concentrations |
| Q44369576 | Steep barriers to overcome for successful application of stem cell treatment in patients with idiopathic pulmonary fibrosis. |
| Q22306396 | Stem Cell Treatment for Chronic Lung Diseases |
| Q37890845 | Stem cell therapy in pulmonary fibrosis. |
| Q49885622 | Taking a giant step in the diagnosis of idiopathic pulmonary fibrosis |
| Q24810989 | Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis |
| Q88561163 | The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis |
| Q51503959 | The Six-Minute Stepper Test: Solvitur ambulando. |
| Q39376424 | The Varied Manifestation of Pulmonary Artery Agenesis in Adulthood |
| Q80058691 | The clinician through the looking glass: sputum microbiology in COPD exacerbations |
| Q44543412 | The cost of COPD exacerbations: a university hospital--based study in Greece. |
| Q48286706 | The effect of bronchodilation and spirometry on fractional exhaled nitric oxide (FeNO50), bronchial NO flux (JawNO) and alveolar NO concentration (CANO) in children and young adults. |
| Q45254077 | The effect of obesity on pulmonary lung function of school aged children in Greece |
| Q84120631 | The microbiology of bacterial lung abscess: time for a reappraisal? |
| Q38055722 | The pathogenesis of pulmonary fibrosis: a moving target |
| Q24802498 | The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome |
| Q42161988 | The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. |
| Q43965029 | The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. |
| Q78500214 | The trans-exudative pleural effusion |
| Q84559088 | This issue of Current Opinion in Pulmonary Medicine contains articles that readers will find informative and challenging |
| Q38882654 | Toll-like receptors in the pathogenesis of pulmonary fibrosis |
| Q50597305 | Tuberculin sensitivity trends in Hellenic army recruits during the period 1981-91. |
| Q37054044 | Update on pleural disease: introduction. |
| Q83874742 | Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis |
| Q24799684 | Use of interrupter technique in assessment of bronchial responsiveness in normal subjects |
| Q52969808 | Usual interstitial pneumonia pattern in the diagnosis of idiopathic pulmonary fibrosis? |
| Q37391291 | Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. |
| Q79819733 | Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure? |
| Q37543259 | γ -H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer. |
| Q36409165 | γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. |
Search more.